112 related articles for article (PubMed ID: 20128783)
1. Prognostic significance of survivin-expressing circulating tumour cells in T1G3 bladder cancer.
Gradilone A; Petracca A; Nicolazzo C; Gianni W; Cortesi E; Naso G; Vincenzi B; Cristini C; De Berardinis E; Di Silverio F; Aglianò AM; Gazzaniga P
BJU Int; 2010 Sep; 106(5):710-5. PubMed ID: 20128783
[TBL] [Abstract][Full Text] [Related]
2. The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC).
Nicolazzo C; Busetto GM; Del Giudice F; Sperduti I; Giannarelli D; Gradilone A; Gazzaniga P; de Berardinis E; Raimondi C
J Cancer Res Clin Oncol; 2017 Oct; 143(10):1971-1976. PubMed ID: 28555356
[TBL] [Abstract][Full Text] [Related]
3. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
[TBL] [Abstract][Full Text] [Related]
4. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
[TBL] [Abstract][Full Text] [Related]
5. Using detection of survivin-expressing circulating tumor cells in peripheral blood to predict tumor recurrence following curative resection of gastric cancer.
Cao W; Yang W; Li H; Lou G; Jiang J; Geng M; Xi W; Ren R; Qu Q; Jin X; Zhu Y; Jin Y
J Surg Oncol; 2011 Feb; 103(2):110-5. PubMed ID: 21259243
[TBL] [Abstract][Full Text] [Related]
6. survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma.
Ikeguchi M; Kaibara N
Br J Cancer; 2002 Oct; 87(8):883-7. PubMed ID: 12373603
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of detecting survivin-expressing circulating cancer cells in patients with non-small cell lung cancer.
Yie SM; Lou B; Ye SR; He X; Cao M; Xie K; Ye NY; Lin R; Wu SM; Xiao HB; Gao E
Lung Cancer; 2009 Feb; 63(2):284-90. PubMed ID: 18606477
[TBL] [Abstract][Full Text] [Related]
8. [Does the initial or secondary status of T1G3 bladder tumours have a prognostic impact?].
Ouaki F; Irani J; Pires C; Breton X; Levillain P; Doré B
Prog Urol; 2006 Feb; 16(1):40-4. PubMed ID: 16526538
[TBL] [Abstract][Full Text] [Related]
9. [Bladder preservation or initial cystectomy in T1G3 bladder cancer: which parameters help in therapeutic decision-making?].
Denzinger S; Burger M; Fritsche HM; Ganzer R; Blana A; Wieland WF; Otto W
Aktuelle Urol; 2008 Jan; 39(1):58-61; discussion 62-3. PubMed ID: 18228189
[TBL] [Abstract][Full Text] [Related]
10. Identification of survivin, an inhibitor of apoptosis, in canine urinary bladder transitional cell carcinoma.
Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Rucker EB; Knapp DW; Rodriguez CO; Green JA
Vet Comp Oncol; 2008 Sep; 6(3):141-50. PubMed ID: 19178674
[TBL] [Abstract][Full Text] [Related]
11. Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer.
Rink M; Chun FK; Minner S; Friedrich M; Mauermann O; Heinzer H; Huland H; Fisch M; Pantel K; Riethdorf S
BJU Int; 2011 May; 107(10):1668-75. PubMed ID: 20735381
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer.
Moussa O; Abol-Enein H; Bissada NK; Keane T; Ghoneim MA; Watson DK
J Urol; 2006 Jun; 175(6):2312-6. PubMed ID: 16697865
[TBL] [Abstract][Full Text] [Related]
13. Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer.
Eissa S; Swellam M; Shehata H; El-Khouly IM; El-Zayat T; El-Ahmady O
J Urol; 2010 Feb; 183(2):493-8. PubMed ID: 20006858
[TBL] [Abstract][Full Text] [Related]
14. Detection of circulating tumour cells in breast cancer patients using human mammaglobin RT-PCR: association with clinical prognostic factors.
Ferro P; Franceschini MC; Bacigalupo B; Dessanti P; Falco E; Fontana V; Gianquinto D; Pistillo MP; Fedeli F; Roncella S
Anticancer Res; 2010 Jun; 30(6):2377-82. PubMed ID: 20651396
[TBL] [Abstract][Full Text] [Related]
15. Survivin gene expression in chronic liver disease and hepatocellular carcinoma.
Montorsi M; Maggioni M; Falleni M; Pellegrini C; Donadon M; Torzilli G; Santambrogio R; Spinelli A; Coggi G; Bosari S
Hepatogastroenterology; 2007; 54(79):2040-4. PubMed ID: 18251156
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of CDC91L1 (PIG-U) in bladder urothelial cell carcinoma: correlation with clinical variables and prognostic significance.
Shen YJ; Ye DW; Yao XD; Trink B; Zhou XY; Zhang SL; Dai B; Zhang HL; Zhu Y; Guo Z; Wu G; Nagpal J
BJU Int; 2008 Jan; 101(1):113-9. PubMed ID: 17941920
[TBL] [Abstract][Full Text] [Related]
17. Survivin expression is associated with bladder cancer presence, stage, progression, and mortality.
Shariat SF; Ashfaq R; Karakiewicz PI; Saeedi O; Sagalowsky AI; Lotan Y
Cancer; 2007 Mar; 109(6):1106-13. PubMed ID: 17311310
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL and disease prognostication after radical prostatectomy.
Giesing M; Suchy B; Driesel G; Molitor D
BJU Int; 2010 Apr; 105(7):1000-10. PubMed ID: 19818074
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of survivin expression in patients with hepatocellular carcinoma.
Chau GY; Lee AF; Tsay SH; Ke YR; Kao HL; Wong FH; Tsou AP; Chau YP
Histopathology; 2007 Aug; 51(2):204-18. PubMed ID: 17559540
[TBL] [Abstract][Full Text] [Related]
20. Emmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer.
Als AB; Dyrskjøt L; von der Maase H; Koed K; Mansilla F; Toldbod HE; Jensen JL; Ulhøi BP; Sengeløv L; Jensen KM; Orntoft TF
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4407-14. PubMed ID: 17671123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]